S&P 500

5.469,30

0,39%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Inotek Pharmaceuticals Corp. (delisted) (ITEK)
Inotek Pharmaceuticals Corp. (delisted) (ITEK) Notícias

ITEK

INOTEK PHARMACEUTICALS CORP (ITEK)

Inotek Pharmaceuticals Corp. (delisted)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ITEK

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/02/2018	20:51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
31/01/2018	17:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
25/01/2018	20:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
25/01/2018	19:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
19/01/2018	20:03	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
19/01/2018	16:52	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
16/01/2018	19:09	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
11/01/2018	19:32	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
22/12/2017	19:52	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
04/12/2017	19:13	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
20/11/2017	20:02	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
08/11/2017	11:03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
12/10/2017	18:20	Business Wire	Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy C...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
12/10/2017	18:08	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
18/09/2017	17:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
12/09/2017	19:06	Business Wire	INSERTING & REPLACING Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of Fi...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
12/09/2017	17:15	Business Wire	Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Ther...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
03/08/2017	17:01	Business Wire	Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
07/07/2017	17:01	Business Wire	Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial of Trabodenoson & Provides Corporat...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
10/05/2017	08:00	Business Wire	Inotek Pharmaceuticals Corporation Reports First Quarter 2017 Financial Results and Operational Highlights	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
08/05/2017	17:05	Business Wire	Inotek Pharmaceuticals Presents Preclinical Data on Trabodenoson at the Association for Research in Vision & Ophthalmology (A...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
26/04/2017	17:48	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
11/04/2017	08:00	Business Wire	Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combination (FDC) of Trabodenoson and Latanoprost	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
23/03/2017	08:47	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
16/03/2017	08:43	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
16/03/2017	08:00	Business Wire	Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results and Operational Highlights	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
27/02/2017	09:00	Business Wire	Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
24/02/2017	22:22	PR Newswire (US)	URGENT: Monteverde & Associates PC Invites Inotek Pharmaceuticals Corporation Shareholders with Losses To Contact The Firm Im...	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
24/02/2017	09:00	Business Wire	Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)
10/02/2017	12:00	Business Wire	Inotek Pharmaceuticals to Present at the BIO CEO and Investor Conference	NASDAQ:ITEK	Inotek Pharmaceuticals Corp. (delisted)